Overview
Charlene Ives is a Hematologist Oncology specialist and an Oncologist in Troy, New York. Dr. Ives is rated as an Advanced provider by MediFind in the treatment of Richter Syndrome. Her top areas of expertise are Mantle Cell Lymphoma (MCL), Paget Disease of the Breast, Childhood Iron Deficiency Anemia, and Iron Deficiency Anemia.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
258 Hoosick St, Suite 206, Troy, NY 12180
Berkshire Faculty Services Inc
Sean Mullally is a Hematologist Oncology specialist and a Hematologist in Pittsfield, Massachusetts. Dr. Mullally is rated as a Distinguished provider by MediFind in the treatment of Richter Syndrome. His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Richter Syndrome, Paget Disease of the Breast, and Familial Colorectal Cancer.
Dartmouth-Hitchcock Clinic
James Nickerson is an Oncologist and a Hematologist in Brattleboro, Vermont. Dr. Nickerson is rated as a Distinguished provider by MediFind in the treatment of Richter Syndrome. His top areas of expertise are Richter Syndrome, Chronic Lymphocytic Leukemia (CLL), Non-Hodgkin Lymphoma, Chronic B-Cell Leukemia (CBCL), and Bone Marrow Aspiration. Dr. Nickerson is currently accepting new patients.
Mass General Brigham Medical Group Western Massachusetts Inc
Barrett Newsome is a Hematologist Oncology specialist and a Hematologist in Northampton, Massachusetts. Dr. Newsome is rated as a Distinguished provider by MediFind in the treatment of Richter Syndrome. His top areas of expertise are Richter Syndrome, Chronic Lymphocytic Leukemia (CLL), Colorectal Cancer, and Lynch Syndrome. Dr. Newsome is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Breast CancerDr. Ives isDistinguished. Learn about Breast Cancer.
- Childhood Iron Deficiency AnemiaDr. Ives isDistinguished. Learn about Childhood Iron Deficiency Anemia.
- Colorectal CancerDr. Ives isDistinguished. Learn about Colorectal Cancer.
- Iron Deficiency AnemiaDr. Ives isDistinguished. Learn about Iron Deficiency Anemia.
- Lynch SyndromeDr. Ives isDistinguished. Learn about Lynch Syndrome.
- Mantle Cell Lymphoma (MCL)Dr. Ives isDistinguished. Learn about Mantle Cell Lymphoma (MCL).
- Advanced
- Acute Eosinophilic PneumoniaDr. Ives isAdvanced. Learn about Acute Eosinophilic Pneumonia.
- Acute Lymphoblastic Leukemia (ALL)
- AgranulocytosisDr. Ives isAdvanced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung Cancer
- AnemiaDr. Ives isAdvanced. Learn about Anemia.
- AngiosarcomaDr. Ives isAdvanced. Learn about Angiosarcoma.
- Experienced
- Acute Mountain SicknessDr. Ives isExperienced. Learn about Acute Mountain Sickness.
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Ives isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Acute Myelomonocytic LeukemiaDr. Ives isExperienced. Learn about Acute Myelomonocytic Leukemia.
- Acute Promyelocytic LeukemiaDr. Ives isExperienced. Learn about Acute Promyelocytic Leukemia.